Central Garden & Pet Company (CENT) Q1 2026 Earnings Call Transcript
Net Sales $617 million, a 6% year-over-year decline. Reasons: Timing of retailer spring inventory shipments in the Garden and Pet segments, portfolio optimization efforts, rationalizing lower-margin categories, closure of U.K. operations, and transitioning European business to a direct export model.
Non-GAAP Gross Profit $190 million compared with $196 million, while non-GAAP gross margin expanded 100 basis points to 30.8%. Reasons: Productivity gains and improved mix.
Non-GAAP SG&A Expense $166 million, down 1% versus the prior year. As a percentage of sales, it was 26.8% compared with 25.5%. Reasons: Disciplined cost management.
Non-GAAP Operating Income $24 million compared with $28 million. Non-GAAP operating margin was 3.9% compared with 4.3%. Reasons: Shipment timing and portfolio optimization efforts.
Non-GAAP Net Income $13 million compared with $14 million in the prior year. Reasons: Shipment timing and portfolio optimization efforts.
Adjusted EBITDA $50 million compared to $55 million. Reasons: Shipment timing and portfolio optimization efforts.
Pet Segment Net Sales $416 million, a 3% year-over-year decline. Reasons: Portfolio optimization efforts, shipments shifting into the second quarter, and temporary shipment hold. Partially balanced by growth in Rawhide and Animal Health businesses.
Pet Segment Non-GAAP Operating Income $50 million compared with $51 million. Non-GAAP operating margin improved to 12.1% from 12%. Reasons: Consistent execution across core categories.
Garden Segment Net Sales $202 million, a 12% decline. Reasons: Shipment timing, transition of third-party distribution product lines, and rationalization of live plants categories. Partially balanced by growth in Wild Bird business.
Garden Segment Non-GAAP Operating Loss $2 million compared with income of $2 million. Non-GAAP operating margin was negative 1.2% compared to positive 1.1%. Reasons: Shipment timing offsetting productivity gains and cost management.
Cash Used by Operations $70 million for the quarter compared with $69 million a year ago. Reasons: Timing of shipments.
CapEx $11 million compared to $6 million. Reasons: Focused investment approach centered on productivity initiatives and essential maintenance.
Cash and Cash Equivalents $721 million, up $103 million. Reasons: Strong liquidity position and cash generation profile.
Total Debt $1.2 billion, unchanged from the prior year. Reasons: Maintenance of financial resilience.
Trade with 70% Backtested Accuracy
Analyst Views on CENT
About CENT
About the author
Three Companies for Steady Wealth Growth
- Strong Performance of Spectrum Brands: In Q1 of fiscal 2026, Spectrum Brands reported an EPS of $1.40, exceeding expectations by 84%, with revenue reaching $677 million, indicating a recovery in its global pet care segment that is expected to drive future growth.
- Expansion Plans of Central Garden & Pet: Central Garden & Pet had a solid start to fiscal 2026, with management asserting that the current stock price is undervalued, announcing a $100 million expansion of its share buyback program, reflecting confidence in future growth.
- Acquisition Strategy of Prestige Consumer Healthcare: Prestige Consumer Healthcare achieved $283.4 million in revenue in Q3 of fiscal 2026, surpassing expectations despite economic challenges, and successfully acquired eye care supplier Pillar5 Pharma, further strengthening its market position.
- Long-term Wealth Building Potential: All three companies focus on brand acquisition and integration, demonstrating robust wealth growth potential through sustained profitability and cash flow generation in uncertain market conditions.
Central Garden & Pet Company Announces Upcoming Investor Conferences
- Investor Conference Participation: Central Garden & Pet Company will participate in upcoming investor conferences, showcasing its leadership in the pet and garden industries, which is expected to attract investor interest and enhance market confidence.
- Financial Performance Overview: The company anticipates net sales of $3.1 billion for fiscal 2025, demonstrating strong performance and growth potential in the market, further solidifying its industry leadership.
- Brand Diversity: Central Garden & Pet Company boasts a diversified portfolio of market-leading brands, including Amdro® and Aqueon®, which enhances brand recognition and competitive positioning among consumers.
- Sustainability Commitment: The company is dedicated to promoting home health through innovative and sustainable solutions, reflecting its commitment to environmental responsibility and enhancing brand image and consumer loyalty.
CENTRAL GARDEN & PET CO RECEIVES APPROVAL TO BUY BACK UP TO $100 MILLION IN STOCK
- Central Garden & Pet Company: Authorized to purchase up to $100 million of its own stock.
- Stock Buyback Program: Aimed at enhancing shareholder value and reflects confidence in the company's future.
CENTRAL GARDEN & PET REVEALS EXPANSION OF STOCK REPURCHASE PROGRAM
Central Garden & Pet Announcement: Central Garden & Pet has announced an increase in stock repurchase authorization, allowing the company to buy back more of its shares.
Purpose of Repurchase: The stock repurchase is aimed at enhancing shareholder value and reflects the company's confidence in its financial position and future growth prospects.
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has announced the appointment of Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, which is expected to bring extensive leadership experience in consumer products and animal health to the company.
- Extensive Industry Background: Schwichtenberg has over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health, indicating her expertise will likely drive innovation and growth for the company.
- Strategic Value Addition: Bill Brown, Chairman of the Board, noted that Schwichtenberg's operational and executive perspective will add value to the Board, aiding the company in focusing on long-term value creation and market growth.
- Educational and Professional Credentials: Schwichtenberg holds an MBA from the University of Illinois at Chicago and has held leadership positions in various industry associations, showcasing her broad influence and leadership capabilities within the industry.
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has appointed Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, aiming to leverage her extensive experience in the animal health sector to drive company growth.
- Rich Industry Experience: Schwichtenberg brings over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health until her retirement in February 2023, demonstrating her deep understanding of the company.
- Leadership Recognition: Bill Brown, Chairman of the Board, stated that Schwichtenberg's leadership experience and profound understanding of consumer products and animal health will provide crucial support for the company's focus on innovation and long-term value creation, further enhancing corporate governance.
- Outstanding Educational Background: Schwichtenberg holds an MBA from the University of Illinois at Chicago and completed the Advanced Executive Program at London Business School, showcasing her expertise in business management, which can significantly contribute to strategic decision-making within the company.
Three Companies for Steady Wealth Growth
- Strong Performance of Spectrum Brands: In Q1 of fiscal 2026, Spectrum Brands reported an EPS of $1.40, exceeding expectations by 84%, with revenue reaching $677 million, indicating a recovery in its global pet care segment that is expected to drive future growth.
- Expansion Plans of Central Garden & Pet: Central Garden & Pet had a solid start to fiscal 2026, with management asserting that the current stock price is undervalued, announcing a $100 million expansion of its share buyback program, reflecting confidence in future growth.
- Acquisition Strategy of Prestige Consumer Healthcare: Prestige Consumer Healthcare achieved $283.4 million in revenue in Q3 of fiscal 2026, surpassing expectations despite economic challenges, and successfully acquired eye care supplier Pillar5 Pharma, further strengthening its market position.
- Long-term Wealth Building Potential: All three companies focus on brand acquisition and integration, demonstrating robust wealth growth potential through sustained profitability and cash flow generation in uncertain market conditions.
Central Garden & Pet Company Announces Upcoming Investor Conferences
- Investor Conference Participation: Central Garden & Pet Company will participate in upcoming investor conferences, showcasing its leadership in the pet and garden industries, which is expected to attract investor interest and enhance market confidence.
- Financial Performance Overview: The company anticipates net sales of $3.1 billion for fiscal 2025, demonstrating strong performance and growth potential in the market, further solidifying its industry leadership.
- Brand Diversity: Central Garden & Pet Company boasts a diversified portfolio of market-leading brands, including Amdro® and Aqueon®, which enhances brand recognition and competitive positioning among consumers.
- Sustainability Commitment: The company is dedicated to promoting home health through innovative and sustainable solutions, reflecting its commitment to environmental responsibility and enhancing brand image and consumer loyalty.
CENTRAL GARDEN & PET CO RECEIVES APPROVAL TO BUY BACK UP TO $100 MILLION IN STOCK
- Central Garden & Pet Company: Authorized to purchase up to $100 million of its own stock.
- Stock Buyback Program: Aimed at enhancing shareholder value and reflects confidence in the company's future.
CENTRAL GARDEN & PET REVEALS EXPANSION OF STOCK REPURCHASE PROGRAM
Central Garden & Pet Announcement: Central Garden & Pet has announced an increase in stock repurchase authorization, allowing the company to buy back more of its shares.
Purpose of Repurchase: The stock repurchase is aimed at enhancing shareholder value and reflects the company's confidence in its financial position and future growth prospects.
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has announced the appointment of Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, which is expected to bring extensive leadership experience in consumer products and animal health to the company.
- Extensive Industry Background: Schwichtenberg has over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health, indicating her expertise will likely drive innovation and growth for the company.
- Strategic Value Addition: Bill Brown, Chairman of the Board, noted that Schwichtenberg's operational and executive perspective will add value to the Board, aiding the company in focusing on long-term value creation and market growth.
- Educational and Professional Credentials: Schwichtenberg holds an MBA from the University of Illinois at Chicago and has held leadership positions in various industry associations, showcasing her broad influence and leadership capabilities within the industry.
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has appointed Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, aiming to leverage her extensive experience in the animal health sector to drive company growth.
- Rich Industry Experience: Schwichtenberg brings over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health until her retirement in February 2023, demonstrating her deep understanding of the company.
- Leadership Recognition: Bill Brown, Chairman of the Board, stated that Schwichtenberg's leadership experience and profound understanding of consumer products and animal health will provide crucial support for the company's focus on innovation and long-term value creation, further enhancing corporate governance.
- Outstanding Educational Background: Schwichtenberg holds an MBA from the University of Illinois at Chicago and completed the Advanced Executive Program at London Business School, showcasing her expertise in business management, which can significantly contribute to strategic decision-making within the company.
